{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:40:43Z","timestamp":1761561643074},"reference-count":6,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T00:00:00Z","timestamp":1336953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T00:00:00Z","timestamp":1336953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1111\/j.1365-2710.2012.01337.x","type":"journal-article","created":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T15:38:11Z","timestamp":1337009891000},"page":"604-606","source":"Crossref","is-referenced-by-count":7,"title":["Genetic predisposition to atorvastatin-induced myopathy: a case report"],"prefix":"10.1155","volume":"37","author":[{"given":"M.","family":"Francesca Notarangelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Marziliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Antonietta Demola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pigazzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Guidorossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Angelica Merlini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ardissino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,5,14]]},"reference":[{"key":"10.1111\/j.1365-2710.2012.01337.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2710.2012.01337.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.atherosclerosis.2009.11.033","article-title":"The genetics of statin-induced myopathy","volume":"210","author":"Ghatak","year":"2010","journal-title":"Atheroclerosis"},{"key":"10.1111\/j.1365-2710.2012.01337.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187569209787582349","article-title":"Pharmacogenetics of HMG-CoA reductase inhibitors: optimizing the prevention of coronary heart disease","volume":"7","author":"Hu","year":"2009","journal-title":"Curr Pharmacogenomics Person Med"},{"key":"10.1111\/j.1365-2710.2012.01337.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy - a genomewide Study","volume":"359","author":"The SEARCH Collaborative Group","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2710.2012.01337.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jacc.2009.04.053","article-title":"The SCLO1B1 genetic variant is associated with statin-induced side effects","volume":"54","author":"Voora","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2710.2012.01337.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/gm120","article-title":"Pharmacogenomic insights into treatment and management of statin-induced myopathy","volume":"1","author":"Peters","year":"2009","journal-title":"Genome Med"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2012.01337.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2012.01337.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2012.01337.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:31Z","timestamp":1671818671000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2012.01337.x"}},"subtitle":["Pharmacogenetic of statins"],"short-title":[],"issued":{"date-parts":[[2012,5,14]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2012.01337.x","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,14]]}}}